| Value | ₹72.50 Cr |
|---|
BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹433.55
- Market cap
- ₹16,588 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 350.2×Sector 43.0×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Kuber Jagdale as Executive Director for 60 months, effective 7 November 2026. He brings over three decades of pharmaceutical manufacturing and operations experience.
Cohance Lifesciences Earnings Call Transcript: Key Takeaways
Q2 revenue rose about 13% QoQ to ₹477 Cr and adjusted EBITDA reached about ₹46 Cr (~10% margin), but both remain below last year. H2 YoY growth is promised without figures, and FY27 specialty chemicals guidance was cut to decline.
Cohance Lifesciences Results Update
Cohance Lifesciences issued a press release on its unaudited Q2 and H1 FY27 results. It reported lower year-on-year revenue and an expected stronger second half.
Cohance Lifesciences Investor Presentation: Key Takeaways
Q2FY27 revenue INR 4,766 Mn, down 14.2% YoY but up 12.9% QoQ. Adjusted EBITDA margin 9.6%, adjusted PAT INR 74 Mn back positive. Strategy centres on One Cohance integration and H2 recovery.
Cohance Lifesciences Q2 FY27 Results: Net Profit ₹2.3 Cr, Down 96.5% YoY
Cohance Lifesciences Ltd reported revenue from operations of ₹476.6 Cr (-14.2% YoY) and net profit of ₹2.3 Cr (-96.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.3 Cr · -96.5% YoY
Other credit rating announcements
All →Manorama Industries Credit Rating
Manorama Industries Ltd disclosed that India Ratings upgraded its bank loan facilities to IND A+/Positive/IND A1+. The rated facilities total INR 4,967.70 million.
HBL Engineering Credit Rating
HBL Engineering's CARE rating was revised, with long-term rating reaffirmed at CARE AA-; Stable. Long-term/short-term facilities were assigned a stable outlook with short-term CARE A1+ reaffirmed.
Metal Coatings (India) Credit Rating
Acuité Ratings reaffirmed Metal Coatings' long-term ACUITE BBB and short-term ACUITE A3+ ratings on bank loans. The rated facilities total Rs 15 Crore, with a stable outlook.
Shyam Metalics and Energy Credit Rating
CRISIL reaffirmed Shyam Metalics' long-term AA+ and short-term A1+ ratings with Stable outlook, plus its Rs. 50 Crore commercial paper rating. The action is dated 2026-11-04 and verified.
Mangalam Global Enterprise Credit Rating
Acuite assigned BBB+ and provisional A- ratings to the company's NCDs, totalling Rs 135 crore. Both ratings carry a Stable outlook.
Chennai Petroleum Corporation Credit Rating
Chennai Petroleum Corporation reports that Crisil reaffirmed its AAA/Stable and A1+ ratings on its bank facilities and commercial paper. The updated credit rating list is hosted on the company website.